nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—Flatulence—Etidronic acid—Paget's disease of bone	0.0031	0.0031	CcSEcCtD
Gliclazide—Asthma—Risedronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Gliclazide—Oedema peripheral—Alendronate—Paget's disease of bone	0.00304	0.00304	CcSEcCtD
Gliclazide—Angina pectoris—Risedronate—Paget's disease of bone	0.00301	0.00301	CcSEcCtD
Gliclazide—Gastritis—Pamidronate—Paget's disease of bone	0.00301	0.00301	CcSEcCtD
Gliclazide—Bronchitis—Risedronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Gliclazide—Abdominal discomfort—Risedronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Gliclazide—Erythema multiforme—Alendronate—Paget's disease of bone	0.00291	0.00291	CcSEcCtD
Gliclazide—Anaemia—Etidronic acid—Paget's disease of bone	0.00291	0.00291	CcSEcCtD
Gliclazide—Angioedema—Etidronic acid—Paget's disease of bone	0.00288	0.00288	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.00287	0.00287	CcSEcCtD
Gliclazide—Leukopenia—Etidronic acid—Paget's disease of bone	0.00282	0.00282	CcSEcCtD
Gliclazide—Pneumonia—Risedronate—Paget's disease of bone	0.00277	0.00277	CcSEcCtD
Gliclazide—Gastritis—Zoledronate—Paget's disease of bone	0.00275	0.00275	CcSEcCtD
Gliclazide—Depression—Risedronate—Paget's disease of bone	0.00275	0.00275	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00273	0.00273	CcSEcCtD
Gliclazide—Abdominal distension—Zoledronate—Paget's disease of bone	0.0027	0.0027	CcSEcCtD
Gliclazide—Erythema—Alendronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Gliclazide—Asthma—Zoledronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Gliclazide—Arthralgia—Etidronic acid—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Gliclazide—Conjunctivitis—Risedronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Gliclazide—Urinary tract infection—Risedronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Gliclazide—Discomfort—Etidronic acid—Paget's disease of bone	0.00265	0.00265	CcSEcCtD
Gliclazide—Flatulence—Alendronate—Paget's disease of bone	0.00264	0.00264	CcSEcCtD
Gliclazide—Pneumonia—Pamidronate—Paget's disease of bone	0.00263	0.00263	CcSEcCtD
Gliclazide—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.0026	0.0026	CcSEcCtD
Gliclazide—Confusional state—Etidronic acid—Paget's disease of bone	0.00259	0.00259	CcSEcCtD
Gliclazide—Sinusitis—Risedronate—Paget's disease of bone	0.00258	0.00258	CcSEcCtD
Gliclazide—Renal failure—Pamidronate—Paget's disease of bone	0.00257	0.00257	CcSEcCtD
Gliclazide—Abdominal discomfort—Zoledronate—Paget's disease of bone	0.00257	0.00257	CcSEcCtD
Gliclazide—Infection—Etidronic acid—Paget's disease of bone	0.00255	0.00255	CcSEcCtD
Gliclazide—Pancytopenia—Zoledronate—Paget's disease of bone	0.00255	0.00255	CcSEcCtD
Gliclazide—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Gliclazide—Urinary tract infection—Pamidronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Gliclazide—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00249	0.00249	CcSEcCtD
Gliclazide—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00249	0.00249	CcSEcCtD
Gliclazide—Anaemia—Alendronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Gliclazide—Rhinitis—Risedronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Gliclazide—Sinusitis—Pamidronate—Paget's disease of bone	0.00246	0.00246	CcSEcCtD
Gliclazide—Pharyngitis—Risedronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Gliclazide—Angioedema—Alendronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Gliclazide—Agranulocytosis—Pamidronate—Paget's disease of bone	0.00244	0.00244	CcSEcCtD
Gliclazide—Weight increased—Zoledronate—Paget's disease of bone	0.00244	0.00244	CcSEcCtD
Gliclazide—Oedema peripheral—Risedronate—Paget's disease of bone	0.00244	0.00244	CcSEcCtD
Gliclazide—Malaise—Alendronate—Paget's disease of bone	0.00242	0.00242	CcSEcCtD
Gliclazide—Depression—Zoledronate—Paget's disease of bone	0.00238	0.00238	CcSEcCtD
Gliclazide—Rhinitis—Pamidronate—Paget's disease of bone	0.00236	0.00236	CcSEcCtD
Gliclazide—Renal failure—Zoledronate—Paget's disease of bone	0.00235	0.00235	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00234	0.00234	CcSEcCtD
Gliclazide—Urinary tract infection—Zoledronate—Paget's disease of bone	0.00232	0.00232	CcSEcCtD
Gliclazide—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00232	0.00232	CcSEcCtD
Gliclazide—Eye disorder—Risedronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Gliclazide—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Gliclazide—Tinnitus—Risedronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Gliclazide—Myalgia—Alendronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Gliclazide—Chest pain—Alendronate—Paget's disease of bone	0.00228	0.00228	CcSEcCtD
Gliclazide—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Gliclazide—Discomfort—Alendronate—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Gliclazide—Agranulocytosis—Zoledronate—Paget's disease of bone	0.00223	0.00223	CcSEcCtD
Gliclazide—Arrhythmia—Risedronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Gliclazide—Constipation—Etidronic acid—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Gliclazide—Eye disorder—Pamidronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Gliclazide—Bradycardia—Zoledronate—Paget's disease of bone	0.00219	0.00219	CcSEcCtD
Gliclazide—Flushing—Pamidronate—Paget's disease of bone	0.00218	0.00218	CcSEcCtD
Gliclazide—Infection—Alendronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Gliclazide—Mental disorder—Risedronate—Paget's disease of bone	0.00217	0.00217	CcSEcCtD
Gliclazide—Malnutrition—Risedronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Gliclazide—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Gliclazide—Flatulence—Risedronate—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Gliclazide—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Gliclazide—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00211	0.00211	CcSEcCtD
Gliclazide—Chills—Pamidronate—Paget's disease of bone	0.00211	0.00211	CcSEcCtD
Gliclazide—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.0021	0.0021	CcSEcCtD
Gliclazide—Back pain—Risedronate—Paget's disease of bone	0.00208	0.00208	CcSEcCtD
Gliclazide—Malnutrition—Pamidronate—Paget's disease of bone	0.00205	0.00205	CcSEcCtD
Gliclazide—Erythema—Pamidronate—Paget's disease of bone	0.00205	0.00205	CcSEcCtD
Gliclazide—Urticaria—Etidronic acid—Paget's disease of bone	0.00204	0.00204	CcSEcCtD
Gliclazide—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00203	0.00203	CcSEcCtD
Gliclazide—Tension—Pamidronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Gliclazide—Eye disorder—Zoledronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00199	0.00199	CcSEcCtD
Gliclazide—Flushing—Zoledronate—Paget's disease of bone	0.00199	0.00199	CcSEcCtD
Gliclazide—Anaemia—Risedronate—Paget's disease of bone	0.00199	0.00199	CcSEcCtD
Gliclazide—Nervousness—Pamidronate—Paget's disease of bone	0.00199	0.00199	CcSEcCtD
Gliclazide—Back pain—Pamidronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Gliclazide—Angioedema—Risedronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Gliclazide—Dyspepsia—Alendronate—Paget's disease of bone	0.00193	0.00193	CcSEcCtD
Gliclazide—Chills—Zoledronate—Paget's disease of bone	0.00193	0.00193	CcSEcCtD
Gliclazide—Arrhythmia—Zoledronate—Paget's disease of bone	0.00192	0.00192	CcSEcCtD
Gliclazide—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Gliclazide—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Gliclazide—Loss of consciousness—Risedronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Gliclazide—Anaemia—Pamidronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Gliclazide—Mental disorder—Zoledronate—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Gliclazide—Agitation—Pamidronate—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Gliclazide—Cough—Risedronate—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Gliclazide—Pain—Alendronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Gliclazide—Constipation—Alendronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Gliclazide—Angioedema—Pamidronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Gliclazide—Erythema—Zoledronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Gliclazide—Malnutrition—Zoledronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Gliclazide—Hypertension—Risedronate—Paget's disease of bone	0.00186	0.00186	CcSEcCtD
Gliclazide—Malaise—Pamidronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Gliclazide—Chest pain—Risedronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Gliclazide—Myalgia—Risedronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Gliclazide—Arthralgia—Risedronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Gliclazide—Leukopenia—Pamidronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Gliclazide—Anxiety—Risedronate—Paget's disease of bone	0.00183	0.00183	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00182	0.00182	CcSEcCtD
Gliclazide—Pruritus—Etidronic acid—Paget's disease of bone	0.00182	0.00182	CcSEcCtD
Gliclazide—Back pain—Zoledronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Gliclazide—Feeling abnormal—Alendronate—Paget's disease of bone	0.0018	0.0018	CcSEcCtD
Gliclazide—Loss of consciousness—Pamidronate—Paget's disease of bone	0.0018	0.0018	CcSEcCtD
Gliclazide—Dry mouth—Risedronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Gliclazide—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Gliclazide—Cough—Pamidronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Gliclazide—Convulsion—Pamidronate—Paget's disease of bone	0.00177	0.00177	CcSEcCtD
Gliclazide—Hypertension—Pamidronate—Paget's disease of bone	0.00177	0.00177	CcSEcCtD
Gliclazide—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00176	0.00176	CcSEcCtD
Gliclazide—Tremor—Zoledronate—Paget's disease of bone	0.00175	0.00175	CcSEcCtD
Gliclazide—Infection—Risedronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Gliclazide—Myalgia—Pamidronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Gliclazide—Arthralgia—Pamidronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Gliclazide—Urticaria—Alendronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Gliclazide—Anxiety—Pamidronate—Paget's disease of bone	0.00174	0.00174	CcSEcCtD
Gliclazide—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Gliclazide—Abdominal pain—Alendronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Gliclazide—Body temperature increased—Alendronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Gliclazide—Anaemia—Zoledronate—Paget's disease of bone	0.00173	0.00173	CcSEcCtD
Gliclazide—Nervous system disorder—Risedronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Gliclazide—Discomfort—Pamidronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Gliclazide—Agitation—Zoledronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Gliclazide—Angioedema—Zoledronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Gliclazide—Skin disorder—Risedronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Gliclazide—Malaise—Zoledronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Gliclazide—Confusional state—Pamidronate—Paget's disease of bone	0.00168	0.00168	CcSEcCtD
Gliclazide—Leukopenia—Zoledronate—Paget's disease of bone	0.00167	0.00167	CcSEcCtD
Gliclazide—Infection—Pamidronate—Paget's disease of bone	0.00166	0.00166	CcSEcCtD
Gliclazide—Palpitations—Zoledronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Gliclazide—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Gliclazide—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Gliclazide—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00163	0.00163	CcSEcCtD
Gliclazide—Vomiting—Etidronic acid—Paget's disease of bone	0.00163	0.00163	CcSEcCtD
Gliclazide—Cough—Zoledronate—Paget's disease of bone	0.00163	0.00163	CcSEcCtD
Gliclazide—Tachycardia—Pamidronate—Paget's disease of bone	0.00163	0.00163	CcSEcCtD
Gliclazide—Rash—Etidronic acid—Paget's disease of bone	0.00162	0.00162	CcSEcCtD
Gliclazide—Convulsion—Zoledronate—Paget's disease of bone	0.00162	0.00162	CcSEcCtD
Gliclazide—Dermatitis—Etidronic acid—Paget's disease of bone	0.00162	0.00162	CcSEcCtD
Gliclazide—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
Gliclazide—Hypertension—Zoledronate—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
Gliclazide—Hypersensitivity—Alendronate—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
Gliclazide—Headache—Etidronic acid—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.0016	0.0016	CcSEcCtD
Gliclazide—Chest pain—Zoledronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Gliclazide—Myalgia—Zoledronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Gliclazide—Arthralgia—Zoledronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Gliclazide—Insomnia—Risedronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Gliclazide—Anxiety—Zoledronate—Paget's disease of bone	0.00159	0.00159	CcSEcCtD
Gliclazide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Gliclazide—Paraesthesia—Risedronate—Paget's disease of bone	0.00158	0.00158	CcSEcCtD
Gliclazide—Discomfort—Zoledronate—Paget's disease of bone	0.00157	0.00157	CcSEcCtD
Gliclazide—Asthenia—Alendronate—Paget's disease of bone	0.00157	0.00157	CcSEcCtD
Gliclazide—Dyspnoea—Risedronate—Paget's disease of bone	0.00157	0.00157	CcSEcCtD
Gliclazide—Hypotension—Pamidronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Gliclazide—Dry mouth—Zoledronate—Paget's disease of bone	0.00156	0.00156	CcSEcCtD
Gliclazide—Pruritus—Alendronate—Paget's disease of bone	0.00155	0.00155	CcSEcCtD
Gliclazide—Dyspepsia—Risedronate—Paget's disease of bone	0.00155	0.00155	CcSEcCtD
Gliclazide—Confusional state—Zoledronate—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
Gliclazide—Nausea—Etidronic acid—Paget's disease of bone	0.00153	0.00153	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00152	0.00152	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00152	0.00152	CcSEcCtD
Gliclazide—Infection—Zoledronate—Paget's disease of bone	0.00152	0.00152	CcSEcCtD
Gliclazide—Fatigue—Risedronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Gliclazide—Insomnia—Pamidronate—Paget's disease of bone	0.00151	0.00151	CcSEcCtD
Gliclazide—Pain—Risedronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Gliclazide—Constipation—Risedronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Gliclazide—Paraesthesia—Pamidronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Gliclazide—Diarrhoea—Alendronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Gliclazide—Nervous system disorder—Zoledronate—Paget's disease of bone	0.0015	0.0015	CcSEcCtD
Gliclazide—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00149	0.00149	CcSEcCtD
Gliclazide—Dyspnoea—Pamidronate—Paget's disease of bone	0.00149	0.00149	CcSEcCtD
Gliclazide—Tachycardia—Zoledronate—Paget's disease of bone	0.00149	0.00149	CcSEcCtD
Gliclazide—Somnolence—Pamidronate—Paget's disease of bone	0.00148	0.00148	CcSEcCtD
Gliclazide—Skin disorder—Zoledronate—Paget's disease of bone	0.00148	0.00148	CcSEcCtD
Gliclazide—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Gliclazide—Dyspepsia—Pamidronate—Paget's disease of bone	0.00147	0.00147	CcSEcCtD
Gliclazide—Dizziness—Alendronate—Paget's disease of bone	0.00145	0.00145	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Gliclazide—Fatigue—Pamidronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Gliclazide—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00144	0.00144	CcSEcCtD
Gliclazide—Pain—Pamidronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Gliclazide—Constipation—Pamidronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Gliclazide—Hypotension—Zoledronate—Paget's disease of bone	0.00143	0.00143	CcSEcCtD
Gliclazide—Urticaria—Risedronate—Paget's disease of bone	0.0014	0.0014	CcSEcCtD
Gliclazide—Vomiting—Alendronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Gliclazide—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Gliclazide—Abdominal pain—Risedronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Gliclazide—Body temperature increased—Risedronate—Paget's disease of bone	0.00139	0.00139	CcSEcCtD
Gliclazide—Rash—Alendronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Gliclazide—Insomnia—Zoledronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Gliclazide—Dermatitis—Alendronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Gliclazide—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00138	0.00138	CcSEcCtD
Gliclazide—Headache—Alendronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Gliclazide—Paraesthesia—Zoledronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Gliclazide—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00137	0.00137	CcSEcCtD
Gliclazide—Dyspnoea—Zoledronate—Paget's disease of bone	0.00136	0.00136	CcSEcCtD
Gliclazide—Somnolence—Zoledronate—Paget's disease of bone	0.00136	0.00136	CcSEcCtD
Gliclazide—Dyspepsia—Zoledronate—Paget's disease of bone	0.00134	0.00134	CcSEcCtD
Gliclazide—Abdominal pain—Pamidronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Gliclazide—Body temperature increased—Pamidronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Gliclazide—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00132	0.00132	CcSEcCtD
Gliclazide—Fatigue—Zoledronate—Paget's disease of bone	0.00131	0.00131	CcSEcCtD
Gliclazide—Constipation—Zoledronate—Paget's disease of bone	0.0013	0.0013	CcSEcCtD
Gliclazide—Pain—Zoledronate—Paget's disease of bone	0.0013	0.0013	CcSEcCtD
Gliclazide—Nausea—Alendronate—Paget's disease of bone	0.0013	0.0013	CcSEcCtD
Gliclazide—Hypersensitivity—Risedronate—Paget's disease of bone	0.00129	0.00129	CcSEcCtD
Gliclazide—Asthenia—Risedronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Gliclazide—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00126	0.00126	CcSEcCtD
Gliclazide—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00125	0.00125	CcSEcCtD
Gliclazide—Pruritus—Risedronate—Paget's disease of bone	0.00124	0.00124	CcSEcCtD
Gliclazide—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00123	0.00123	CcSEcCtD
Gliclazide—Urticaria—Zoledronate—Paget's disease of bone	0.00121	0.00121	CcSEcCtD
Gliclazide—Abdominal pain—Zoledronate—Paget's disease of bone	0.00121	0.00121	CcSEcCtD
Gliclazide—Body temperature increased—Zoledronate—Paget's disease of bone	0.00121	0.00121	CcSEcCtD
Gliclazide—Diarrhoea—Risedronate—Paget's disease of bone	0.0012	0.0012	CcSEcCtD
Gliclazide—Asthenia—Pamidronate—Paget's disease of bone	0.0012	0.0012	CcSEcCtD
Gliclazide—Pruritus—Pamidronate—Paget's disease of bone	0.00118	0.00118	CcSEcCtD
Gliclazide—Dizziness—Risedronate—Paget's disease of bone	0.00116	0.00116	CcSEcCtD
Gliclazide—Diarrhoea—Pamidronate—Paget's disease of bone	0.00114	0.00114	CcSEcCtD
Gliclazide—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00112	0.00112	CcSEcCtD
Gliclazide—Vomiting—Risedronate—Paget's disease of bone	0.00112	0.00112	CcSEcCtD
Gliclazide—Rash—Risedronate—Paget's disease of bone	0.00111	0.00111	CcSEcCtD
Gliclazide—Dermatitis—Risedronate—Paget's disease of bone	0.00111	0.00111	CcSEcCtD
Gliclazide—Dizziness—Pamidronate—Paget's disease of bone	0.0011	0.0011	CcSEcCtD
Gliclazide—Headache—Risedronate—Paget's disease of bone	0.0011	0.0011	CcSEcCtD
Gliclazide—Asthenia—Zoledronate—Paget's disease of bone	0.00109	0.00109	CcSEcCtD
Gliclazide—Pruritus—Zoledronate—Paget's disease of bone	0.00108	0.00108	CcSEcCtD
Gliclazide—Vomiting—Pamidronate—Paget's disease of bone	0.00106	0.00106	CcSEcCtD
Gliclazide—Rash—Pamidronate—Paget's disease of bone	0.00105	0.00105	CcSEcCtD
Gliclazide—Dermatitis—Pamidronate—Paget's disease of bone	0.00105	0.00105	CcSEcCtD
Gliclazide—Headache—Pamidronate—Paget's disease of bone	0.00105	0.00105	CcSEcCtD
Gliclazide—Diarrhoea—Zoledronate—Paget's disease of bone	0.00104	0.00104	CcSEcCtD
Gliclazide—Nausea—Risedronate—Paget's disease of bone	0.00104	0.00104	CcSEcCtD
Gliclazide—Dizziness—Zoledronate—Paget's disease of bone	0.00101	0.00101	CcSEcCtD
Gliclazide—Nausea—Pamidronate—Paget's disease of bone	0.000992	0.000992	CcSEcCtD
Gliclazide—Vomiting—Zoledronate—Paget's disease of bone	0.00097	0.00097	CcSEcCtD
Gliclazide—Rash—Zoledronate—Paget's disease of bone	0.000962	0.000962	CcSEcCtD
Gliclazide—Dermatitis—Zoledronate—Paget's disease of bone	0.000961	0.000961	CcSEcCtD
Gliclazide—Headache—Zoledronate—Paget's disease of bone	0.000955	0.000955	CcSEcCtD
Gliclazide—Nausea—Zoledronate—Paget's disease of bone	0.000906	0.000906	CcSEcCtD
